Sign up to our technology alerts and be the first to hear about any new technology opportunities from Scotland's universities
Please select the market sector you are interested in.
Please select the university you are interested in.
Show only Easy Access opportunities.
Narrow your search with a few keywords.
University: University of Glasgow
Sector(s): Healthcare & Pharmaceuticals, Engineering & Manufacturing
Medical students and practitioners are unable to practice the spinal injection procedure on cadavers, nor can they practice on patients due to the serious danger of spinal injury. Therefore when the procedure has to be carried out, there is an ever present risk of injury to the patient.
Spinal injections are commonly required procedures to remove fluid to carry out biochemical, and microbiological test and also to allow drug delivery.
The University of Glasgow has created a Spinal Injection Simulator which is essential to develop the skills of medical practitioners. This device provides accurate spine articulation, mimics human tissue properties and enables realistic touch/feel and spinal fluid removal feedback to the practitioner.
Training aid for medical students and practioners specialising in paediatric care
An academic prototype device has been created and a GB patent application exists for this device:‘Medical demonstration device and method for operating a medical demonstration device’ - GB 0807830.5Contact is welcomed from organisations interested in developing, licensing or exploiting this technology with a view to commercialisation
Please enter your name.
Please enter the name of the company you work for.
Is your company an SME?
Please select the country you are in.
Please enter your email address.
Please enter your telephone number.
To help us process your enquiry faster please enter some details about the information you are interested in.
Please prove you are a human by completing this simple image recognition task.
The University of Glasgow has developed novel Cardiac Imaging software to be used in existing Cardiac MRI equipment, automating the current process to reduce potential errors.
The University of Glasgow has developed a (Ad-hTR-NTR) which has been extensively tested on Ovarian cancer cells.
A new rapid and non-invasive test has been developed for detecting early stage glaucoma by researchers at the University of Aberdeen. The test detects abnormalities in visual processing associated with retinal neuropathies such as glaucoma.
Genespark is a fast fluorescent molecular labelling technology with unlimited multiplex scalability.
Researchers at Heriot-Watt have developed a resorbable polymer insert which is capable of timed release (a slow release)of drug preparations to prevent, for example, tooth decay.